SCNI
$0.70
Post-MarketAs of Mar 17, 8:00 PM UTC
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
No recent news found.